Quantgene Launches Serenity Complete, the Next Generation Executive Physical
Serenity Complete uses deep genomics, blood panels and other indicators for the early detection of chronic illnesses.
- Serenity Complete uses deep genomics, blood panels and other indicators for the early detection of chronic illnesses.
- Adherence to the Serenity program is expected to increase the healthy lifespan of members significantly.
- "Executive health is a concern for corporate boards and stockholders, which is why more companies are adopting preventive healthcare programs like Serenity Complete," said Jo Bhakdi, founder and CEO of Quantgene.
- Quantgene is a precision medicine company headquartered in Santa Monica, CA, and Berlin, Germany, with clinical sites across Europe and the US.